Altogex™

Umbilical Cord blood Native Nucleated cells (UCB-NNC)

Human cord blood native nucleated cells (HCBNNCs) are separated from umbilical cord blood using a proprietary protocol. HCBNNCs are screened for the expression of immune marker CD45, and their viability is assessed using Acridine Orange or DAPI staining and our state-of-the-art, fully automated cell counting machine. This highly purified population of cells makes it possible to further isolate specific and rarer populations, as well as additional downstream processes.

The Altogex™ fraction is a result of a validated technology composed of lymphocytes (T cells, B cells, and natural killer cells), monocytes, dendritic cells, and stem/progenitor cells. These cells are important cellular components of the immune system and are essential in effective humoral and cell-mediated immune responses.

Altogex contains T regulatory cells, natural killer cells, hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs),  epithelial stem cells (ESCs), and endothelial stem cells (ENSCs). MUSE cells, very small embryonic-like cells (VSEL).  These cells have broad regenerative capacity and immunomodulatory properties that have been shown to be beneficial. In a variety of in a variety of disease states.